Donor-derived cell-free DNA in liver transplantation: Promise, limitations, and future directions
Transplant Immunology · 2026
DOI: 10.1016/j.trim.2026.102430 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Transplant Immunology, 2026. Verfasst von Zahra Beyzaei und 7 weiteren Autor:innen. Beteiligte Einrichtung: Transplant Research Center (STRC), Shiraz University of Medical Sciences, Shiraz, Iran. Hauptthemen laut MEDLINE: Liver Transplantation, Graft Rejection, Cell-Free Nucleic Acids, Liver. Die Arbeit nennt 35 Literaturangaben.
Abstract (Originalsprache)
Donor-derived cell-free DNA (dd-cfDNA) is an emerging non-invasive biomarker with growing potential for monitoring graft health and detecting rejection after liver transplantation. Several studies suggest that dd-cfDNA may provide a sensitive approach for assessing graft injury and immune-mediated rejection, although its diagnostic performance remains variable across different clinical settings. Increased levels of dd-cfDNA have been associated with episodes of graft injury and may indicate rejection earlier than some currently used biochemical or immunological assays. Liver biopsy remains the gold standard for diagnosing graft rejection; however, it is an invasive procedure that is generally performed after clinical or laboratory abnormalities become evident. Consequently, by the time these tests indicate any unusual or concerning graft activity, the graft may already be damaged by nearly 50%. Therefore, novel biomarkers such as dd-cfDNA may facilitate earlier detection of graft injury and support more timely therapeutic intervention. This review highlights the role of dd-cfDNA in monitoring post-transplant liver status, discusses the limitations of the current diagnostic methods of graft rejection, and explores the current evidence, challenges, and future perspectives of dd-cfDNA as a biomarker in this context.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Transplant Research Center (STRC), Shiraz University of Medical Sciences, Shiraz, Iran.
- School of Medicine, Shahid Beheshti University of Medical Science, Iran.
- School of Medicine, Tehran University of Medical Science, Iran.
- Shiraz Medical School Library, Shiraz University of Medical Sciences, Shiraz, Iran.
- Transplant Research Center (STRC), Shiraz University of Medical Sciences, Shiraz, Iran; Department of Pathology, Shiraz University of Medical Sciences, Shiraz, Iran. Electronic address: geramib@gmail.com.
Zitieren
APA
Beyzaei, Z., Abdollahi, M., Ghafourian, K., Meysami, A., Firouzabadi, S. R., Mohammadi, I., Karimzadeh, S., & Geramizadeh, B. (2026). Donor-derived cell-free DNA in liver transplantation: Promise, limitations, and future directions. Transplant Immunology. https://doi.org/10.1016/j.trim.2026.102430
Vancouver
Beyzaei Z, Abdollahi M, Ghafourian K, Meysami A, Firouzabadi SR, Mohammadi I, et al. Donor-derived cell-free DNA in liver transplantation: Promise, limitations, and future directions. Transplant Immunology. 2026. doi:10.1016/j.trim.2026.102430
BibTeX
@article{Beyzaei2026,
author = {Beyzaei, Zahra and Abdollahi, Melika and Ghafourian, Kiana and Meysami, Anahid and Firouzabadi, Shahryar Rajai and Mohammadi, Ida and Karimzadeh, Sara and Geramizadeh, Bita},
title = {Donor-derived cell-free DNA in liver transplantation: Promise, limitations, and future directions},
journal = {Transplant Immunology},
year = {2026},
doi = {10.1016/j.trim.2026.102430}
}
EUVIMED